Clinical trial Recruiting at 1 site Observational

Understanding Charcot-Marie-Tooth Disease through patient data

Official title: Global Registry for Inherited Neuropathies Natural History Study for Charcot Marie Tooth Disease

Run by Hereditary Neuropathy Foundation · NCT05902351 · Data updated 2026-11-12

This study is collecting information from people with Charcot-Marie-Tooth Disease to better understand their experiences and help improve future treatments.

Quick facts

Study typeObservational
SexAll
Enrollment10000 (estimated)
SponsorHereditary Neuropathy Foundation
Government
Locations1 site (New York, New York)
StatusRecruiting
StartedNovember 1, 2013
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedSeptember 17, 2026
Trial IDNCT05902351 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals of all ages with a confirmed or suspected diagnosis of Charcot-Marie-Tooth Disease or other inherited neuropathies.

Probably not a fit

Patients who do not have Charcot-Marie-Tooth Disease or other inherited neuropathies will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather and analyze patient-reported data, genetic reports, Electronic Health Records (EHRs), and clinical notes related to Charcot-Marie-Tooth Disease (CMT). By documenting the burden and diagnostic journey of individuals with CMT, the study seeks to enhance understanding of the disease's prevalence and characteristics. Participants will complete a Natural History Survey to contribute valuable insights that could inform future research and potential treatments.

Why it matters

Potential benefit: If successful, this study could provide critical data that aids in the development of effective treatments for Charcot-Marie-Tooth Disease.

How similar studies have gone: While this study focuses on natural history, similar observational studies have successfully contributed to understanding other genetic conditions, indicating potential for valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients will be made aware of the study by HNF and others (referenced above) and invited to participate. Once patients have reviewed and signed electronically the informed consent document, it is attached to their file.

All affected individuals with CMT/IN are eligible to participate in GRIN with proper informed consent.

Children, adolescents and adults with either a confirmed diagnosis or suspected to have CMT/IN are eligible with parent and/or guardian consent.

Individuals that have been clinically diagnosed through family history and/or standard clinical testing (e.g. neuro exam, EMG, NCS) and/or genetically tested or suspected to have CMT/IN (note: many mutations have not been identified yet) are eligible.

Exclusion Criteria:

People that do not have Charcot-Marie-Tooth or other Inherited Neuropathies

Where it's running

  • Hereditary Neuropathy Foundation
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.